State Street SPDR S&P Health Care Equipment ETF
XHEDividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 24, 2025 | $0.02 | 2025-12-22 | 2025-12-22 |
| September 24, 2025 | $0.03 | 2025-09-22 | 2025-09-22 |
| June 25, 2025 | $0.02 | 2025-06-23 | 2025-06-23 |
| December 26, 2024 | $0.03 | 2024-12-23 | 2024-12-23 |
| September 25, 2024 | $0.01 | 2024-09-23 | 2024-09-23 |
Dividends Summary
- Consistent Payer: State Street SPDR S&P Health Care Equipment ETF has rewarded shareholders with 52 dividend payments over the past 14 years.
- Total Returned Value: Investors who held XHE shares during this period received a total of $7.45 per share in dividend income.
- Latest Payout: The most recent dividend of $0.02/share was paid 206 days ago, on December 24, 2025.
- Yield & Schedule: XHE currently pays dividends quarterly with an annual yield of 0.11%.
- Dividend Growth: Since 2011, the dividend payout has grown by 69.4%, from $0.01 to $0.02.
Company News
The healthcare sector, down 3.8% year-to-date and the worst performer among S&P 500 sectors, presents selective opportunities despite weak aggregate earnings growth. While the sector faces headwinds with the lowest forward profit margins and weakest 2026 EPS growth outlook, specific subsectors show promise: Pharmaceuticals are rerating as GLP-1 e...
Insulet Corp. (NASDAQ:PODD) shares fell to a 52-week low following the announcement of a voluntary Medical Device Correction for certain Omnipod 5 Pods. The manufacturing defect involves a small tear in internal tubing that delivers insulin, potentially causing under-delivery and serious health complications including diabetic ketoacidosis. The c...
The FDA approved an expanded age indication for Staar Surgical's EVO/EVO+ Visian Implantable Collamer Lenses, extending eligibility from ages 21-45 to 21-60 years old. This could add nearly 8 million refractive patients to the market. The approval is based on three-year clinical trial data showing strong safety profiles. Despite the positive news...
STAAR Surgical shares declined as Broadwood Partners, which owns 31% of the company, gained board influence with two new directors joining alongside Christopher Wang of Yunqi Capital. The changes follow the failed merger with Alcon and include the departure of Chair Elizabeth Yeu, with CEO Stephen Farrell remaining until January 31, 2026. The sto...
Sector ETF report for XHE
